Navigation Links
Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
Date:10/2/2013

ndo con las restantes actividades de solicitud de nuevo fármaco".

La prueba clínica EASED™ Fase 2/3 se creó para investigar la seguridad y la eficacia de tres niveles de dosis de ADS-5102 administradas una vez por la noche, a la hora de acostarse, para el tratamiento de la LID en la PD. En el estudio participaron 83 sujetos que fueron aleatorizados en una relación de 1:1:1:1 para los cuatro grupos de tratamiento: placebo, 260 mg de ADS-5102, 340 mg de ADS-5102 y 420 mg de ADS-5102. Tanto el nivel de dosis de 340 mg como el de 420 mg de ADS-5102 redujeron considerablemente la LID medida por el cambio en la puntuación total de la Escala Unificada para la Evaluación de la Disquinesia (UDysRS) en ocho semanas frente al placebo, alcanzando el punto final primario del estudio clínico. Es de notar que la reducción en la LID se vio a las dos semanas después de la primera dosis de medicamento en el estudio. En la octava semana, el período de respuesta a los medicamentos sin disquinesia molesta, medido por los diarios de los pacientes, fue de 11.0 horas, 11.5 horas y 12.1 horas para los niveles de dosis de 260 mg, 340 mg y 420 mg, respectivamente, en comparación con 8.0 horas para el placebo. Estos resultados fueron estadísticamente significativos, demostrando un incremento de unas 3 horas sobre el placebo en comparación con los valores de la línea de base.  ADS-5102 también mostró una mejora funcional estadísticamente significativa en la disquinesia evaluada según la parte IV de la MDS-Escala Unificada para la Evaluación de la Enfermedad de Parkinson (MDS-UPDRS), una medida del grado de impacto que la disquinesia tiene en la función diaria del paciente en actividades e interacciones sociales.

El tratamiento con ADS-5102 no dio como resultado un empeoramiento de la PD, según la medición de la puntuación combinada de MDS-UP
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
2. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
3. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
4. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
5. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
6. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
7. Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum
8. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
9. Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States
10. Industry Landscape Opens Doors for GeoBargain Polydex Pharmaceuticals
11. Prolong Pharmaceuticals Presents Novel Multi-Pronged Approach To Treating Sickle Cell Disease At The SCDAA Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 More than a third of ... of those with private insurance, filled a prescription for an ... report in this week,s Morbidity and Mortality Weekly Report (MMWR). ... providers to treat moderate to severe pain.  They are also ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... Reportlinker.com announces that a new market research ... Innovations in Wound Care Devices and ... Introduction Wound ... range of sizes, shapes, stages, and types ...
... 2012 /PRNewswire-iReach/ -- Global Information, Inc. (GII) is ... Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts ... The Insulin Delivery Devices Market is ... $11 Billion by 2017 GlobalData estimated ...
Cached Medicine Technology:Innovations in Wound Care Devices and Dressings 2Innovations in Wound Care Devices and Dressings 3Innovations in Wound Care Devices and Dressings 4Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 2Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 3Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 4
(Date:1/22/2015)... 2015 Liberty University has received accreditation for ... from the Council for Accreditation of Counseling & Related ... Center for Counseling & Family Studies , is under ... university’s new School of Behavioral Sciences. Prior to the formation ...
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... boosted physical, mental scores, study finds , , FRIDAY, March ... poor families boosts children,s physical and mental development, a ... of California, Berkeley found that children in low-income families ... from a government-run conditional cash transfer program were taller, ...
... NEW YORK, March 7 Four out of ... dietary supplement every day, according to the,Institute of ... errors are made due to handwritten prescriptions. These ... drug interactions and,allergic reactions., See video ...
... teaching at ... the Medical Center, COLUMBUS, Ohio, March 7 ... last six years accounting,for nearly 50 percent of the region,s net employment ... jobs, says an economic,impact report released today by the Columbus Chamber of ...
... could enable doctors to rule out tuberculosis (TB) infection ... study published this week in the journal Annals of ... College London and the University of Oxford, shows that ... tuberculosis with 99% accuracy when using the new blood ...
... Dr. Lin Mei, chief of developmental neurobiology at the ... Scholar in Neuroscience, has received the 2008 Mathilde Solowey ... administered by Foundation for Advanced Education in the Sciences, ... that is cutting edge, translational and of broad importance. ...
... wont run into grandparents at your local tanning salon? ... a recent health survey of American adults suggests that while ... many as 10 percent of those between 50 and 64 ... 65 tanned indoors. , Researchers at Fox Chase Cancer Center ...
Cached Medicine News:Health News:Government Assistance Linked to Better Child Development 2Health News:Chamber Analysis Shows OSU Medical Center Leads Area Job Growth 2Health News:Chamber Analysis Shows OSU Medical Center Leads Area Job Growth 3Health News:New TB test means quicker and easier diagnosis for patients 2Health News:New TB test means quicker and easier diagnosis for patients 3Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 2Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 3Health News:Teenage girls aren't the only ones who tan indoors -- older adults do so as well 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: